Abstract:Over the last 15 years, a small number of paediatric artemisinin-based combination therapy products have been marketed. These included Riamet® and Coartem® dispersible tablets, a combination of artemether and lumefantrine, co-developed by the Medicines for Malaria Venture and Novartis. Disappointingly, patient compliance, requirement for high-fat meal, and sporadic drug dissolution behaviours following administration still result in considerable challenges for these products. The first and foremost barrier that needs addressed for successful delivery of the artemether/lumefantrine combination is the poor solubility of lumefantrine within the gastrointestinal fluids. In this work, amorphous solid dispersions of lumefantrine within Soluplus®-based matrices have been manufactured using hot melt extrusion as a potential formulation strategy to achieve enhanced dissolution and apparent solubility. The drug loading capacity of Soluplus® to accommodate amorphous lumefantrine, whilst ensuring improved in-vitro dissolution performance, was investigated. The extrusion process employed a variety of processing parameters, including various temperature profiles and different production scales. The influence of variation in extrusion conditions upon the physical stability of manufactured amorphous solid dispersions was also examined. This allowed for a greater understanding of the role of extrusion processing conditions on the performance of supersaturated amorphous solid dispersions during dissolution and storage. This may allow for the design and manufacture of drug enabled formulations with lower drug dosing and thus a lower risk of adverse effects.

Preparation of artemether capsules

Optimal Preparation Process of Artemether by Orthogonal Experiments

Preparation and Quality Control of Levamlodipine Besylate Orally Disintegrating Tablets

Preparation and Properties of a New Artemisinin Lipid Emulsion for Parenteral Administration

Study on Formulation and Technology of Amoxicillin Sulbactam Pivoxil Dispersible Tablets

Optimization of Formulations of 1% Abamectin Microcapsule Suspensions with Properties of Biochemical Materials

Optimization of the Preparation Process for an Oral Phytantriol-Based Amphotericin B Cubosomes

Preparation of Weitengnin Dispersible Tablets

A Method of Synthesizing a Pharmaceutically Acceptable Artemisinin

Optimization of Preparation Process and Pharmacokinetics of APAP Double-Release Pellet Capsules

Prescription Optimization and Quality Evaluation of Andrographolide Self-microemulsion Preparation

Preparation and Quality Control of Alprazolam Orally Disintegrating Tablet

Characteristics of Artemether-Loaded Poly(lactic-co-glycolic) Acid Microparticles Fabricated by Coaxial Electrospray: Validation of Enhanced Encapsulation Efficiency and Bioavailability.

Study on the Optimization of Prescription and Preparation of Matrine Liposomes

Preparation of Amoxicillin-ethylcellulose Microcapsule by In-liquid Drying Method and Its Dissolution Study

Study on Preparation Technology of Epimedii Folium Extract Self-emulsifying Soft Capsule

Preperation and Quality Evaluation of Dehydroandrographolide Self-emulsifying Formulation

Hot Melt Extruded High-Dose Amorphous Solid Dispersions Containing Lumefantrine and Soluplus

[Preparation and Quality Evaluation of Fufangxiaoyepipa Dispersible Tablets].

Co-delivery of Artemether and Piperine Via Core-Shell Microparticles for Enhanced Sustained Release

Preparation and Clinical Application of Suppository Sodium Copper Chlorophyllin